Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02088333 · ClinicalTrials.gov registry record · NA

Effectiveness of an mHealth Colorectal Cancer Screening Intervention

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
450
Enrollment target

NCT02088333: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT02088333 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02088333, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a multilevel mHealth intervention (mCRC) can increase the percentage of patients who receive colorectal cancer screening. The mCRC intervention will include a tablet-based patient education program, clinic protocols to facilitate the ordering of CRC screening tests, and electronic messaging with patients to promote screening. The investigators hypothesize that participants randomized to mCRC will be more likely to complete screening compared with those randomized to the control arm of the study. Additionally, the investigators hypothesize mCRC will increase several intermediate outcomes (such as knowledge, attitudes, beliefs, and test ordering) which will predict completion of screening. Lastly, the investigators hypothesize the mCRC intervention will add little to the overall cost of screening.

Primary Outcome

Patient completion of a colorectal cancer screening test, such as the fecal occult blood test, a flexible sigmoidoscopy, or a colonoscopy.

Interventions

  • BEHAVIORAL mCRC intervention
  • BEHAVIORAL Healthy Lifestyles video

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2014-06
Est. Completion 2016-10
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02088333 record still lists

NCT02088333 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which mCRC intervention is the first listed.

NCT02088333 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02088333 about?

NCT02088333 is a clinical study titled "Effectiveness of an mHealth Colorectal Cancer Screening Intervention". The purpose of this study is to determine whether a multilevel mHealth intervention (mCRC) can increase the percentage of patients who receive colorectal cancer screening. The mCRC intervention will include a tablet-based patient education program, clinic protocols to facilitate the ordering of CRC ...

What is the current status of trial NCT02088333?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2014-06. Estimated completion is 2016-10.

What interventions are being tested in trial NCT02088333?

The interventions under investigation include: mCRC intervention (BEHAVIORAL), Healthy Lifestyles video (BEHAVIORAL).

Who is sponsoring clinical trial NCT02088333?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02088333's enrollment target sits among peer trials

450 225th of 2000 higher than 1,768 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02088333, the US trial registry maintained by the National Library of Medicine. NCT02088333 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.